Skip to main content

Table 2 Regression analysis of observed number of ESRD patients during the period 2004–2015 in the PACA region

From: End-stage renal disease treated in Provence-Alpes Côte d’Azur: 12-years follow-up and forecast to the year 2030

 

β (95% CI)

Exp(β) (95% CI)

p

New patients starting RRT

0.033

(0.027–0.039)

1.034

(1.028–1.039)

< 0.001

Pre-emptive transplant

0.145

(0.105–0.185)

1.156

(1.111–1.203)

< 0.001

New patients starting their first dialysis

0.031

(0.025–0.036)

1.031

(1.025–1.037)

< 0.001

Age: 80 years and more

0.066

(0.056–0.077)

1.069

(1.057–1.080)

< 0.001

None co-morbidity

0.019

(0.007–0.030)

1.019

(1.007–1.031)

0.002

At least one cardiovascular disease

0.055

(0.047–0.063)

1.057

(1.048–1.065)

< 0.001

Diabetes

0.054

(0.045–0.064)

1.056

(1.046–1.066)

< 0.001

Cancer

0.082

(0.062–0.101)

1.085

(1.064–1.106)

< 0.001

Underweight (< 18.5)

0.016

(− 0.010–0.042)

1.016

(0.990–1.043)

0.220

Normal BMI (18.5–24.9)

0.038

(0.029–0.048)

1.039

(1.029–1.049)

< 0.001

Overweight (25.0–29.9)

0.065

(0.053–0.076)

1.067

(1.055–1.079)

< 0.001

Obese (≥ 30)

0.116

(0.100–0.132)

1.123

(1.105–1.141)

< 0.001

DP

0.050

(0.028–0.071)

1.051

(1.028–1.074)

< 0.001

HD

0.029

(0.023–0.035)

1.030

(1.023–1.036)

< 0.001

In-center HD

0.031

(0.025–0.037)

1.031

(1.025–1.038)

< 0.001

HD in medical satellite unit

0.245

(0.201–0.290)

1.278

(1.222–1.336)

< 0.001

HD in self-care unit

− 0.092

(−0.120 − −0.063)

0.913

(0.887–0.939)

< 0.001

Renal transplant performed

0.050

(0.039–0.062)

1.052

(1.039–1.064)

< 0.001

Living donor

0.190

(0.140–0.241)

1.210

(1.150–1.272)

< 0.001

Deceased donor

0.041

(0.029–0.053)

1.042

(1.029–1.055)

< 0.001

Patients receiving RRT

0.036

(0.034–0.038)

1.037

(1.034–1.039)

< 0.001

Patients with a functional renal transplant

0.055

(0.051–0.059)

1.057

(1.053–1.061)

< 0.001

Patints on dialysis

0.026

(0.023–0.029)

1.026

(1.024–1.029)

< 0.001

Age: 80 years and more

0.105

(0.099–0.111)

1.111

(1.104–1.118)

< 0.001

None co-morbidities

0.006

(0.001–0.012)

1.006

(1.001–1.012)

0.027

Diabetes

0.067

(0.062–0.072)

1.070

(1.064–1.075)

< 0.001

Cancer

0.105

(0.094–0.116)

1.111

(1.099–1.123)

< 0.001

At least one CVD

0.059

(0.055–0.063)

1.061

(1.057–1.065)

< 0.001

Underweight (< 18.5)

0.053

(0.041–0.066)

1.055

(1.041–1.069)

< 0.001

Normal BMI (18.5–24.9)

0.076

(0.071–0.081)

1.079

(1.074–1.084)

< 0.001

Overweight (25.0–29.9)

0.097

(0.091–0.103)

1.102

(1.095–1.108)

< 0.001

Obese (≥ 30)

0.131

(0.123–0.139)

1.140

(1.131–1.149)

< 0.001

DP

0.027

(0.014–0.040)

1.027

(1.014–1.041)

< 0.001

HD

0.027

(0.024–0.030)

1.027

(1.024–1.030)

< 0.001

In-center HD

0.019

(0.015–0.022)

1.019

(1.015–1.022)

< 0.001

HD in medical satellite unit

0.311

(0.299–0.324)

1.365

(1.348–1.382)

< 0.001

HD in self-care unit

−0.035

(−0.041 − −0.028)

0.966

(0.960–0.972)

< 0.001

HD at home

−0.159

(−0.182 − −0.136)

0.853

(0.834–0.873)

< 0.001

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us